Navigation Links
Bioforce AG Announces Doctors Comments Showing Efficacy of Echinaforce for Immune Support Now On You Tube
Date:12/20/2012

Roggwil, Switzerland (PRWEB) December 20, 2012

Echinacea is a popular herb used to treat colds and flu in many parts of the world, yet reports on its efficacy have been mixed. With the recent discovery of anti-viral, anti-inflammatory and immune modulating activity, there has been renewed interest in clinical research on Echinacea. According to Roland Schoop, Medical Researcher for Bioforce AG, Switzerland “Despite decades of pharmaceutical research, scientists have not found a specific way to prevent colds or flu. The key reason for this is the enormous variety of viruses causing colds or flu – today, more than 200 different respiratory viruses are known and new viruses are discovered every year. An alternative approach to preventing colds is to build the body’s immune resistance. That is why we have focused so much research on the effect Echinaforce has on the immune system.”

On September 27, 2012 Prof. Stephan Pleschka, Institute for Medical Virology, University Glessen, Germany, Dr. Margaret Ritchie, University of London, Prof. Ronald Eccles, Director of Common Cold Centre, University Cardiff (UK), Dr. Andreas Schapowal, ENT specialist (CH), and Prof. Michael Heinrich, School of Pharmacy, University College, London (UK) gathered in London to discuss the latest research on a Swiss Echinacea extract Echinaforce®. Their comments on the efficacy of Echinaforce® have been are available on You Tube http://www.youtube.com/user/officialechinaforce?feature=watch. The report on this conference is also available by calling 800-641-7555.

Bioforce AG, Rogwill, Switzerland is known for its “gold standard” research on herbs. Bioforce received the American Botanical Council’s Varro E. Tyler Commercial Investment in Phytomedicinal Research Award in 2011. It’s meta-analysis on Echinacea was chosen as one of the top 25 research papers of 2006 by the prestigious Annual Bibliography of Significant Advances in Dietary Supplement Research, published by The National Institutes of Health, (NIH) Office of Dietary Supplements.

About Bioforce
Bioforce USA has created long-term strategic alliances with European manufacturers of product lines that have years of clinical research support for safety and efficacy, plus years of repeat consumer use. Bioforce USA has brought these lines, which include A. Vogel, Sanhelios, Herbatint, Bionorica, Annemarie Börlind and SECURE Denture Adhesives exclusively to the United States for distribution through natural products and health food stores.

For more information call Eileen Sheets at 800-641-7555 x100 or esheets(at)bioforceusa(dot)com

Read the full story at http://www.prweb.com/releases/2012/12/prweb10252805.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Bioforce USA Announces Herbatint Herbal Hair Color Selected For Tips and Trends Again
2. AFAR announces the 2012 Hartford Centers of Excellence in Geriatric Medicine awards
3. Bascom Palmer Eye Institute announces breakthrough for degenerative vision disorder
4. University of Houston Graduate College of Social Work announces partnership with MD Anderson
5. The Ludwig Institute for Cancer Research announces launch of iTeos Therapeutics SA
6. AGA announces prestigious awards recognition recipients
7. TheBestHeartRateMonitorReviews.com Announces The Top 3 Heart Rate Monitors
8. Article Marketing Company Content Writing King Announces Training Of New Graphic Design Artist
9. Zane Benefits Announces Wellness HRAs: A New Way to Reward Healthy Employees
10. San Francisco’s Advanced Male Medical Center Announces Discount, Discusses Erectile Dysfunction
11. Insulite Labs announces the launch of the PCOS Inspiration Hour, a one hour virtual gathering place for women with PCOS and other women’s health issues to come together.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 24, 2017 , ... ... semi-final round of the 2017 Cupid's Cup Entrepreneurship Competition. Chaired by Under Armour ... in 2017. The entrepreneurs will showcase their businesses on February 6, 2017, at ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... today that its annual Solutions Series of webinars will start January 31 with ... discussing a number of current health and benefits topics, including employee engagement, pricing ...
(Date:1/24/2017)... ... January 24, 2017 , ... His message has been heard by more than ... End Distracted Driving , Joel Feldman, has reached his biggest national audience yet: the ... of the top newspapers in circulation in the country, and he hopes it will ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... Center ... 21st century leadership, has named Hector M. Chavez, Manager, Employee & Labor Relations at ... center - as its Hispanic Leader of the Month. City of Hope is committed ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... ... is the focus of a new report from the Frank Hawkins Kenan ... School. , Influential business leaders, academics and policy makers identified concrete solutions at ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... Aptuit, LLC, hat heute den ... Massachusetts General Hospital (MGH) unter Leitung von Dr. ... Identifizierung und Validierung neuartiger Targets in gramnegativen Bakterien.  Aptuit ... von Antibiotika bei der Behandlung schwerer Infektionen entgegenwirken können. ... ...
(Date:1/24/2017)... -- Laboratory Markets Limited has completed a comprehensive market ... both clinical and research laboratory settings. This study, which ... $6.8 billion and growing to $9.2 billion (CAGR of ... of mass spectrometry across more than 5,200 clinical and ... in the use of mass spectrometry in terms of ...
(Date:1/24/2017)... 2017 Global Market for Pharmaceutical ... A majority of medicines & drugs produced in ... (API), and such processes require alcoholic solvents such as ... of pharmaceutical solvents continues to be concentrated in the ... (APEJ) region as leading API suppliers and ...
Breaking Medicine Technology: